Filing Flows › Dare Bioscience (DARE) › Stock forecast & fair value
Dare Bioscience (DARE) stock forecast and price target
Dare Bioscience (DARE) trades at $0.64. 3 analysts' median price target is $5.00 (+682%), from $2.00 to $12.00.
Dare Bioscience's latest quarter
Dare Bioscience, Q2 2026: revenue $188K, net loss $3.0M, operating cash flow −$6.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for DARE stock?
The median of 3 analysts' 12-month targets is $5.00, +682% from $0.64; the range is $2.00 to $12.00. The average rating is strong buy.
Does Dare Bioscience usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is DARE stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.